Haemovigilance in the Hospital and State-wide

来源 :BIT`s 1st Annual International Symposium of Hematology-2012( | 被引量 : 0次 | 上传用户:q412202242
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background and Aim The STIR (Serious Transfusion Incident Reporting) voluntary haemovigilance system developed by the Blood Matters program commenced with a pilot in 2006.Hospitals and laboratories from Victoria, Tasmania, the Northern Territory and the Canberra Hospital in Australia now participate.The system aims to:· Measure and monitor serious transfusion incidents, including near misses, relating to administration and handling of fresh components and pretransfusion samples.· Derive recommendations for better, safer transfusion practice and disseminate these to health services, state and federal governments and the Australian Red Cross Blood Service.Method, Results and Conclusions Since 2006 STIR has been notified from 51 institutions of 998 transfusion episodes resulting in 1009 adverse events (In 2009-10, 214 events were reported with a denominator of 440,591 blood components issued, frequency of event 1∶2058).The majority (55%) were associated with red cells and acute reactions were the most frequently reported event type 50 per cent (n=496)).Procedural errors, including near misses accounted for 43% of all events, with "wrong blood in tube" the most common of these at 25% and "incorrect blood component transfused" at 7% events, including 6 ABO incompatible transfusions.No deaths related to the events were reported.Reporting is a two-step process, with initial notification followed by an in-depth investigative form tailored to the type of event reported.During 2010-11 further steps were taken towards online reporting and automation of data management to simplify the process and improve the quality of data.Case review at an institutional level (e.g.by local transfusion committee) prior to reporting to STIR also contributes to data quality and completeness.All cases are reviewed by members of a multidisciplinary expert panel.A biennial report of general demographics and deidentified case studies is utilised to disseminate information widely to health services and availably publicly.Its aim is to provide recommendations and safety tips, to assist health services to improve local transfusion practice.Although many events were unavoidable providing that the transfusion was appropriate, the number of "near misses" and incorrect blood component transfused highlights the potential for serious consequences and need for ongoing practice improvement.
其他文献
The most abundant protein in blood is hemoglobin (Hb, 12-15 g/dL in blood).This fact indicates that oxygen transport is the most crucial for life activity.Hb is compartmentalized in red blood cells (R
会议
Extracellular soluble hemoglobins (Hbs) have long been studied for their possible use as safe and effective alternatives to blood transfusion.While remarkable progress has been made in the use of cell
会议
Adequate blood components support is essential in the management of ABO mismatched allogeneic hematopoietic progenitor cell transplant (HPCT) patients.We performed a retrospective analysis of 71 HLA m
会议
Introduction: Thromboelastography is a viscoelastic clot assay that uses whole blood to generate a dynamic realtime tracing of the clot, from formation to degradation and includes more information abo
会议
Bone morphogenetic proteins (BMPs) induce apoptosis and growth arrest in multiple myeloma (MM) cells.The mechanism for BMP-induced apoptosis has not been clear;however we have proposed that BMP-induce
会议
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is an autocrine and a paracrine cytokine.It stimulates growth, differentiation and function of normal and leukemic myeloid progenitors.GM-CSF
会议
Histone H2AX plays an important role in regulation of tumor cell apoptosis and acts as a novel human tumor suppressor protein.However, it is still unknown how H2AX phosphorylation at Ser 139 and Tyr 1
会议
High concentration of fetal hemoglobin (HbF) of above 1% of the total hemoglobin, is a well established feature of patients with hematological and solid tumors.As such, HbF has been considered an indi
会议
Objective: Our aim is to detect the expression profile ofNK ligands in acute leukemia cell lines and investigate the differential expression pattern between acute lymphoblastic leukemia (ALL) and acut
To investigate the effects of quercetin on proliferation and apoptosis ofleukemiacells, and explore its possible mechanism of action and provide a theoretical basis for its clinical application.We use
会议